@article{f33a6b8a0621459f8a02cf0a1fd716c1,
title = "Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis: a retrospective observational study",
abstract = "Cyclosporine (CsA) or infliximab (IFX) are used as rescue therapies in steroid-refractory, severe attacks of ulcerative colitis (UC). There are no data comparing the efficacy of these two alternatives.",
author = "Mats Sj{\"o}berg and Andrea Walch and Mina Meshkat and Anders Gustavsson and Gunnar J{\"a}rnerot and Harald Vogelsang and Erik Hertervig and Gottfried Novacek and Ingalill Friis-Liby and Lars Blomquist and Sieglinde Angelberger and Per Karlen and Christer Gr{\"a}nn{\"o} and Mogens Vilien and Magnus Str{\"o}m and Hans Verbaan and Hellstr{\"o}m, {Per M} and Clemens Dejaco and Anders Magnuson and Jonas Halfvarson and Walter Reinisch and Curt Tysk",
note = "Copyright {\textcopyright} 2011 Crohn's & Colitis Foundation of America, Inc.",
year = "2012",
doi = "10.1002/ibd.21680",
language = "English",
volume = "18",
pages = "212--8",
journal = "Inflammatory Bowel Diseases",
issn = "1078-0998",
publisher = "Oxford University Press",
number = "2",
}